<DOC>
	<DOCNO>NCT01063569</DOCNO>
	<brief_summary>Addison 's disease rare condition case cause autoimmune destruction adrenal , lead deficiency cortisol , aldosterone adrenal androgen . Unrecognized disease life threatening , proper treatment patient live near normal life . The conventional glucocorticoid replacement therapy render cortisol level unphysiological , may cause symptom long-term complication . Glucocorticoid replacement therapy technically feasible continuous subcutaneous hydrocortisone infusion ( CSHI ) , mimic normal diurnal cortisol rhythm . This study aim evaluate CSHI treatment term metabolic effect , effect health-related quality-of-life sleep 8 month randomise open label clinical trial crossover design .</brief_summary>
	<brief_title>Glucocorticoid Treatment Addison 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Addison Disease</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Patients verify Addison 's disease stable treatment . Insulin treat Diabetes Mellitus , cardiovascular disease , malignant disease , pregnancy . Treatment glucocorticoid drug interfere cortisol metabolism ( antiepileptic , rifampicin , St. John 's wart ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Addison 's disease</keyword>
	<keyword>Glucocorticoid treatment</keyword>
	<keyword>Continuous subcutaneous hydrocortisone infusion</keyword>
	<keyword>CSHI</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Sleep</keyword>
</DOC>